🚨💊HUGE news: @US_FDA has finally granted approval to @ShionogiUS’s Xocova (Ensitrelvir), a 2nd-generation antiviral targeting SARS-CoV-2. The approval is for the indication of “post-exposure prophylaxis of COVID-19 following contact with an individual who has COVID-19”.